An advisory panel to the US Food and Drug Administration Thursday voted to recommend a booster shot from for many Americans, at least six months after their second dose.
The panel voted unanimously in favor of a half-dose injection for people over 65, people over 18 at high risk for severe COVID-19, and people over 18 whose jobs put them at risk for COVID-19 infection. 19. These are thelast month.
the COVID-19 vaccines are highly effective in the prevention of hospitalization and death. During the summer, when the delta variant took hold in the US, the number of COVID-19 cases, hospitalizations and deaths increased. Those who are not vaccinated have counted – more than 97% as of July.
While the US already offers a only 2.5% of people living in low-income countries You have received at least one dose of vaccine.for some people,
The FDA panel’s vote is not binding, but the agency will likely accept the recommendation. FDAless than a week after an advisory panel made its recommendation.
The FDA has already granted an emergency authorization for a third dose of Moderna vaccine for some immunosuppressed adults.
The panel will meet again on Friday to discuss a booster dose for Johnson & Johnson’s COVID-19 vaccine.